Detalhe da pesquisa
1.
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Br J Dermatol
; 190(2): 258-265, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792727
2.
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
Br J Haematol
; 202(2): 267-278, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221131
3.
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
Eur Respir J
; 61(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080573
4.
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Br J Clin Pharmacol
; 85(3): 570-579, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511379
5.
Perip7lakin is a target for autoimmunity in asthma.
Respir Res
; 17(1): 126, 2016 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717390
6.
Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).
J Am Acad Dermatol
; 74(6): 1166-72, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26947449
7.
Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.
Front Immunol
; 15: 1243566, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686381
8.
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Ann Rheum Dis
; 72(3): 357-62, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580581
9.
A polymorphous bullous dermatosis.
Lancet Oncol
; 18(12): e776, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208443
10.
Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med
; 183(6): 759-66, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20935114
11.
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Front Immunol
; 13: 874108, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514989
12.
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Front Immunol
; 13: 915205, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844526
13.
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.
Front Med (Lausanne)
; 6: 249, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750309
14.
Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.
Semin Arthritis Rheum
; 48(1): 83-89, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191376
15.
A second locus mapping to 2q35-36 for familial pseudohyperkalaemia.
Eur J Hum Genet
; 12(12): 1073-6, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15470366
16.
Levels of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in healthy newborn cord sera.
Thromb Haemost
; 99(6): 1124-6, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18521522
17.
Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme.
JAMA Dermatol
; 154(4): 487-489, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29450445
18.
Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Joint Bone Spine
; 76(3): 248-53, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208451
19.
Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
Arthritis Res Ther
; 11(3): R87, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19515233
20.
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.
Arthritis Res Ther
; 10(6): R142, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19077182